Chris Edwards | 03/30/2020

On March 24, Southern University of Science and Technology (SUSTech) Chair Professor of Biomedical Engineering Xingyu JIANG was elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).

Dr. Jiang was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions in using micro-/nano-materials for multiplexed assays that improves the quality of healthcare and efficiency of biomedical research.”

Under special procedures, Dr. Jiang was remotely inducted along with 156 colleagues who make up the AIMBE College of Fellows Class of 2020.

The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization that represents the most accomplished individuals in the fields of medical and biological engineering. AIMBE’s mission is to provide leadership and advocacy in medical and biological engineering for the benefit of society. It is an organization of leaders in medical and biological engineering, consisting of academic, industrial, professional society councils and elected fellows. The College of Fellows is comprised of experts in areas such as clinical practice, industrial practice, and education. Potential Fellows go through a rigorous peer-review and selection process.

Chair Professor Xingyu JIANG’s research interests include microfluidic chips and nano-biomedicine. Dr. Xingyu JIANG received funding from the National Outstanding Youth Science Fund in 2010, the Top Youth in 2013, the Special Allowance of the State Council in 2014, the Innovative Talents Promotion Plan of the Ministry of Science and Technology, and the Chief Scientist in the Key Special Project of the National Key Research and Development Plan of the Ministry of Science and Technology in 2019. He was one of the inaugural winners of the Xplorer Prizes from the Tencent Foundation in 2019. He has published more than 300 papers, and his research directions include microfluidic chips and nano-biomedicine.